Life Sciences weekly highlights—23 October 2025
This week's edition of Life Sciences weekly highlights includes news on the UK Administrative Court’s decision to dismiss a judicial review challenging a refusal to be included in the pharmaceutical list for distance selling premises (R (Medis Pharma) v NHS Resolution), the European Commission adopted its sixth and final implementing regulation for joint clinical assessments of medical devices under the Health Technology Assessment Regulation, and the MHRA selected seven AI healthcare technologies for the second phase of its AI Airlock regulatory sandbox programme. Also included, is news that the European Parliament’s Environment, Public Health and Food Safety (ENVI) Committee will vote on its draft opinion regarding environmental aspects of the Commission’s Critical Medicines Act following 119 tabled amendments, the EMA updated its FAQ guidance document on parallel distribution, the European Commission adopted its 2026 Work Programme, the DHSC and NHS England published positive time-saving findings from the world’s largest healthcare AI trial and the UK government announced a funding boost for regional science and technology sectors, among other stories.